Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients

The tyrosine kinase Inhibitor (TKI) imatinib is approved for the treatment of the chronic phase of chronic myeloid leukemia (CP-CML). Pharmacokinetic studies have highlighted the importance of inter-patient variability on imatinib plasma trough concentrations (ima[C]min). In the OPTIM-imatinib trial...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Main Authors: Heriberto Bruzzoni-Giovanelli (Author), Habib Zouali (Author), Mourad Sahbatou (Author), Benjamin Maneglier (Author), Jean-Michel Cayuela (Author), Angelita Rebollo (Author), Gustavo H. Marin (Author), Daniela Geromin (Author), Carole Tomczak (Author), Antonio Alberdi (Author), Jean-Francois Deleuze (Author), Philippe Rousselot (Author)
Format: Bog
Udgivet: MDPI AG, 2024-06-01T00:00:00Z.
Fag:
Online adgang:Connect to this object online.
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Internet

Connect to this object online.

3rd Floor Main Library

Detaljer om beholdninger fra 3rd Floor Main Library
Klassifikationsnummer: A1234.567
Kopi 1 Tilgængelig